Revenue, Adjusted EBITDA 1 and EPS above top end of guidance New agreements drive record Smartphone ARR2 Company reaffirms full year 2026 ...
Can WuXi AppTec’s Integrated Discovery Platform Power Oncology? WuXi AppTec’s integrated platform combines high-authority screening, pharmacology, and early assessment in a single end-to-end system.
Human-in-the-loop oversight is widely invoked as a safeguard against potential harm from artificial intelligence (AI) used in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results